Welcome, Guest!
Sign in
or
Register
|
Contact Us & Provide Feedback
Get Quotes & Predictions
Enter stock or index
HOME
MAKE
PREDICTIONS
TODAY'S
FORECASTS
CONTESTS &
GAMES
COMMUNITY
LEADERS
BOARDS &
BLOGS
STOCK QUOTES
& NEWS
MY PAGE
Active Forecasts
Peregrine Pharmaceuticals Inc. (PPHM)
Last:
0.34
Change:
0.00 (0.00%)
Volume:
77,573
After Hours:
0.34
Sign in to edit your portfolio
You need to download
Flash Player
and enable JavaScript to see Graphical Prediction Interface!
Return to Standard View
intraday
week
month
year
5 years
Recent PPHM Comments
There are no comments for this symbol.
PPHM News
Peregrine Pharmaceuticals begins dosing in Phase II trial of bavituximab
PPHM: Begins Ph II Trial of Bavituximab for Advanced Breast Cancer
Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
*Peregrine Pharmaceuticals Doses First Patient In Phase II Trial Of Bavituximab In Patients With Advanced Breast Cancer
PRESS RELEASE: Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Related Stocks
MOT
Motorola, Inc.
loading please wait...
RAD
Rite Aid Corp.
loading please wait...
WM
Washington Mutual Inc.
loading please wait...
S
Sprint Nextel Corp
loading please wait...
ALU
Alcatel-Lucent
loading please wait...
Join our stock prediction community!
Whether you know a lot or a little about picking stocks, your predictions help us all make better investment decisions.
Join now... it's free
!
PPHM Stock Data
Last Trade:
7:30 PM 8/27/2008
Prev Close:
0.34
Open:
0.34
Bid:
0.32
Ask:
0.84
Day's Range:
0.33 - 0.34
52wk Range:
0.31 - 0.79
Market Cap:
76,911,700
P/E:
-3.00
EPS (ttm):
-0.10
Div & Yield:
N/A (N/A)
PPHM Experts
No one qualifies as an expert.
Think you can be an expert on PPHM? Make predictions and see how accurate you can be.
Help & Support
Contact our support team
.